Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

316 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging drugs for the treatment of bone metastasis.
Pantano F, Iuliani M, Zoccoli A, Fioramonti M, De Lisi D, Fioroni I, Ribelli G, Santoni M, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: zoccoli a. Expert Opin Emerg Drugs. 2015;20(4):637-51. doi: 10.1517/14728214.2015.1062876. Epub 2015 Jun 25. Expert Opin Emerg Drugs. 2015. PMID: 26113304 Review.
New targets, new drugs for metastatic bone pain: a new philosophy.
Pantano F, Zoccoli A, Iuliani M, Lanzetta G, Vincenzi B, Tonini G, Santini D. Pantano F, et al. Among authors: zoccoli a. Expert Opin Emerg Drugs. 2011 Sep;16(3):403-5. doi: 10.1517/14728214.2011.588600. Epub 2011 May 31. Expert Opin Emerg Drugs. 2011. PMID: 21623686
Premetastatic niche: ready for new therapeutic interventions?
Zoccoli A, Iuliani M, Pantano F, Imperatori M, Intagliata S, Vincenzi B, Marchetti P, Papapietro N, Denaro V, Tonini G, Santini D. Zoccoli A, et al. Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S119-29. doi: 10.1517/14728222.2012.656092. Epub 2012 Mar 23. Expert Opin Ther Targets. 2012. PMID: 22443277 Review.
MicroRNAs and bone metastasis: a new challenge.
Croset M, Santini D, Iuliani M, Fioramonti M, Zoccoli A, Vincenzi B, Tonini G, Pantano F. Croset M, et al. Among authors: zoccoli a. Molecules. 2014 Jul 11;19(7):10115-28. doi: 10.3390/molecules190710115. Molecules. 2014. PMID: 25019555 Free PMC article. Review.
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.
Santini D, Zoccoli A, Gregorj C, Di Cerbo M, Iuliani M, Pantano F, Zamarchi R, Sergi F, Flammia G, Buscarini M, Rizzo S, Cicero G, Russo A, Vincenzi B, Avvisati G, Tonini G. Santini D, et al. Among authors: zoccoli a. Oncology. 2013;85(6):342-7. doi: 10.1159/000347226. Epub 2013 Dec 3. Oncology. 2013. PMID: 24335337 Clinical Trial.
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer.
Pantano F, Rossi E, Iuliani M, Facchinetti A, Simonetti S, Ribelli G, Zoccoli A, Vincenzi B, Tonini G, Zamarchi R, Santini D. Pantano F, et al. Among authors: zoccoli a. Sci Rep. 2020 Jan 28;10(1):1288. doi: 10.1038/s41598-020-58339-2. Sci Rep. 2020. PMID: 31992773 Free PMC article. Clinical Trial.
New molecular targets in bone metastases.
Santini D, Galluzzo S, Zoccoli A, Pantano F, Fratto ME, Vincenzi B, Lombardi L, Gucciardino C, Silvestris N, Riva E, Rizzo S, Russo A, Maiello E, Colucci G, Tonini G. Santini D, et al. Among authors: zoccoli a. Cancer Treat Rev. 2010 Nov;36 Suppl 3:S6-S10. doi: 10.1016/S0305-7372(10)70013-X. Cancer Treat Rev. 2010. PMID: 21129612 Review.
316 results